https://clinicaltrials.gov/ct2/show/NCT03447262?recrs=abdf&type=Intr&cond=Cystic+Fibrosis&lupd_s=02%2F04%2F2019&lupd_d=14
Condition : Cystic Fibrosis
Interventions : Drug: VX-659; Drug: TEZ; Drug: IVA
Sponsor : Vertex Pharmaceuticals Incorporated
Enrolling by invitation
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
NCT03447262
Tue, 27 Feb 2018 12:00:00 EST
Last Update Posted: 02/18/19 10:26AM